Previous findings indicated that GP130 signaling, induced by IL-6 ligands, may switch-off the responsiveness to IL-27, through the induction of the suppressor of cytokine signaling, SOCS3, in human hepatocellular carcinoma cells [29]. This evidence concerns the gene SOCS3 and hepatocellular carcinoma.